gms | German Medical Science

56. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie e. V. (DGNC)
3èmes journées françaises de Neurochirurgie (SFNC)

Deutsche Gesellschaft für Neurochirurgie e. V.
Société Française de Neurochirurgie

07. bis 11.05.2005, Strasbourg

Chronic hydrocephalus: outcome predictors

Chronischer Hydrozephalus: Prädiktoren des klinischen Ergebnisses

Meeting Abstract

Suche in Medline nach

  • corresponding author M. Kiefer - Saarland University, Department of Neurosurgery
  • R. Eymann - Saarland University, Department of Neurosurgery
  • W. I. Steudel - Saarland University, Department of Neurosurgery

Deutsche Gesellschaft für Neurochirurgie. Société Française de Neurochirurgie. 56. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie e.V. (DGNC), 3èmes journées françaises de Neurochirurgie (SFNC). Strasbourg, 07.-11.05.2005. Düsseldorf, Köln: German Medical Science; 2005. Doc10.05.-16.01

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter:

Veröffentlicht: 4. Mai 2005

© 2005 Kiefer et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen ( Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.




Selection criteria for patients with chronic hydrocephalus are still enigmatic. Objective of this prospective study was to find outcome predictors for patients with chronic hydrocephalus (CH).


125 patients with chronic hydrocephalus of various origins were examined. CSF-dynamics, length of anamnesis, preoperative clinical state, age and Co-morbidities (with a new ranking scale: Co-Morbidity-Index (CMI)) were examined as outcome predictors. All patients received a gravitational valve. Outcome was measured with an own classification (HHS) and with Black’s scale. Statistics: Spearman-test, Kruskal-Wallis-test, U-test at a significance level <0.005.


ROF alone had a positive predictive value (PPV) of 63% and a negative predictive value (NPV) of 37%. PPV and NPV of PVI were somewhat better. However the combination of ROF and PVI provided the best PPV (79%) and NPV (68%) regarding CSF-dynamics. Statistically significant correlations were found between outcome and length of a anamnesis (p=0.001), preoperative clinical state (p=0.003) and Co-morbidity state (p=0.001), which had a negative influence on regeneration potential. Cerebral white matter disease (CWD), hypertension, diabetes mellitus, presence of M.Parkinson and a generalized occlusive vascular disease had the utmost negative effects, while a preceding cardiac disease influenced outcome not. Age is not an independent predictor of outcome. If Co-Morbidity is low (CMI < 3 points) and / or preoperative clinical state exhibits only a moderate obstruction (HHS < 6 points) the probability for a substantial clinical benefit from shunting is >90%.


Shunt surgery should be performed as early as possible, because the rehabilitation potential decreases with an anamnesis longer than 1 year. To wait for the complete Hakim Trias is unfounded. Delayed surgery is only acceptable, if clinical obstructions are mild and Co-Morbidity is low. Patients’ age per se may not be taken as an argument against surgery, if Co-Morbidity is low or clinical obstruction is mild. Of utmost importance is the co-morbidity state. If CMI is > 3 points rehabilitation chances fall dramatically. In the light of invasiveness the value of CSF-hydrodynamics is disputable regarding the predictive value.